Page last updated: 2024-09-02

exp3174 and arachidonyltrifluoromethane

exp3174 has been researched along with arachidonyltrifluoromethane in 1 studies

Compound Research Comparison

Studies
(exp3174)
Trials
(exp3174)
Recent Studies (post-2010)
(exp3174)
Studies
(arachidonyltrifluoromethane)
Trials
(arachidonyltrifluoromethane)
Recent Studies (post-2010) (arachidonyltrifluoromethane)
2362943240134

Protein Interaction Comparison

ProteinTaxonomyexp3174 (IC50)arachidonyltrifluoromethane (IC50)
Fatty-acid amide hydrolase 1Homo sapiens (human)1.0082
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)2.3
Cytosolic phospholipase A2 betaHomo sapiens (human)0.8
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)2.3
Cytosolic phospholipase A2Homo sapiens (human)2.3
Fatty-acid amide hydrolase 1Rattus norvegicus (Norway rat)3.7
Platelet-activating factor acetylhydrolaseHomo sapiens (human)0.8
Monoglyceride lipaseHomo sapiens (human)6.3833
Cytosolic phospholipase A2 gammaHomo sapiens (human)0.42

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bassenge, E; Schwemmer, M; Sommer, O1

Other Studies

1 other study(ies) available for exp3174 and arachidonyltrifluoromethane

ArticleYear
Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling.
    Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:4

    Topics: Angiotensin Receptor Antagonists; Animals; Arachidonic Acids; Benzimidazoles; Biphenyl Compounds; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Imidazoles; Losartan; Phospholipases A; Phospholipases A2; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Thromboxane; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Thromboxane A2

2001